Stroke-associated pneumonia research over the past 2 decades has yielded significant insight into SAP risk factors, diagnostic measures, and management strategies.
Researchers sought to assess the short-term benefit and risk of ticagrelor with aspirin in patients with acute mild-moderate ischemic stroke or high-risk transient ischemic attack.
Stroke survivors who participate in a comprehensive stroke recovery program that incorporates modified cardiac rehabilitation have decreased all-cause mortality at 1 year, improved overall function, and better cardiovascular performance.
For adults hospitalized with SARS-CoV-2 infection, encephalopathy at admission is the most common serious neurologic manifestation, all of which are associated with worse outcomes.
The online “Prevent 2nd Stroke” (P2S) behavior change intervention improves stroke survivors’ self-reported global ratings of health-related quality of life (HRQoL) at six months.
For patients with ischemic stroke due to large vessel occlusion who undergo mechanical thrombectomy (MT), predictors against re-employment include female sex and persistent functional deficits.
Researchers sought to evaluate the efficacy of various VR treatments compared with conventional therapy in improvement of the physical and psychological status of patients with stroke.